Percutaneous Cryoablation of Plasmacytomas: Oncologic Effectiveness and Adverse Events.

Abstract

PURPOSE:

To evaluate the oncologic outcomes and adverse events associated with cryoablation of plasmacytomas.

MATERIALS AND METHODS:

Retrospective review of an institutional percutaneous ablation database showed that 43 patients underwent 46 percutaneous cryoablation procedures for treatment of 44 plasmacytomas between May 2004 and March 2021. The treatment of 25 (25 of 44, 56.8%) tumors was augmented with bone consolidation/cementoplasty. The median patient age was 64 years (interquartile range [IQR], 54-69), and 30 of 43 (69.8%) patients were men. The median maximum plasmacytoma diameter was 5.0 cm (IQR, 3.1-7.0). Thirty of 44 (68.2%) tumors were periacetabular, vertebral, or located in the iliac wing. Twenty-nine of 44 (65.9%) cryoablated plasmacytomas were recurrent tumors after prior external beam radiation therapy (EBRT). Survival analyses were performed using the Kaplan-Meier method. Adverse events were graded using Society of Interventional Radiology criteria.

RESULTS:

The 5-year estimated local tumor recurrence-free survival was 85.3% (95% CI, 74.1%-98.1%), the 5-year estimated new plasmacytoma-free survival was 49.9% (95% CI, 33.9%-73.4%), and the 5-year estimated overall survival was 70.4% (95% CI, 56.9%-87.1%). Nine of 46 (19.6%) major adverse events occurred in 8 patients, including 3 of 46 (6.5%) new or progressive pathologic fractures at the ablation site requiring surgical intervention, 3 of 46 (6.5%) nerve injuries, 1 of 46 (2.2%) avascular necrosis and femoral head collapse, 1 of 46 (2.2%) septic arthritis, and 1 of 46 (2.2%) acute renal failure caused by rhabdomyolysis.

CONCLUSIONS:

Percutaneous cryoablation is a viable treatment option for patients with plasmacytomas, including those with recurrent plasmacytomas after EBRT. Postcryoablation adverse events are relatively common.

• Authors: Grant D Schmit, A Nicholas Kurup, Johnathan M Morris, Shaji K Kumar, John J Schmitz, Brian T Welch, Blake A Kassmeyer, Matthew R Callstrom
• Journal: Journal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 34 Issue 8 Pg. 1303-1310 (08 2023) ISSN: 1535-7732 [Electronic] United States
• PMID: 37100197 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 SIR. Published by Elsevier Inc. All rights reserved.

Topics

• Male
• Humans
• Middle Aged
• Female
• Kidney Neoplasms (pathology)
• Treatment Outcome
• Cryosurgery (methods)
• Neoplasm Recurrence, Local (surgery)
• Carcinoma, Renal Cell (surgery)
• Retrospective Studies